-
Signature
-
/s/ Matthew Gilmartin, Attorney-in-Fact for Ronald E Bruehlman
-
Issuer symbol
-
IQV
-
Transactions as of
-
20 Jul 2021
-
Net transactions value
-
+$3,189
-
Form type
-
4
-
Filing time
-
14 Feb 2022, 16:06:43 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IQV |
Common Stock |
Purchase |
$3,189 |
+13 |
+0.06% |
$245.32 |
20,355 |
20 Jul 2021 |
Direct |
|
| transaction |
IQV |
Common Stock |
Award |
$0 |
+5,869 |
+29% |
$0.000000 |
26,224 |
10 Feb 2022 |
Direct |
F1 |
| holding |
IQV |
Common Stock |
|
|
|
|
|
11,880 |
20 Jul 2021 |
By Trust |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IQV |
Stock Appreciation Right |
Award |
$0 |
+21,849 |
|
$0.000000 |
21,849 |
10 Feb 2022 |
Common Stock |
21,849 |
$250.43 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
EVP & Chief Financial Officer